C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 8, 2003
Grant Date -
Mar 7, 2002
app pub date -
Dec 19, 2000
filing date -
Jul 2, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully